BHVN 2026-08-27 Biohaven: Sale Of Opakalim Rights To SK Biopharmaceuticals Makes Sense On Many Levels
Edmund Ingham NYSE
Biohaven Ltd.
BHVN
1 article
$2.2B Market cap · 2026-08-26
BHVN 2026-08-27 Edmund Ingham BHVN 2026-08-27 Edmund Ingham 
NYSE
BHVN
1 article
$2.2B Market cap · 2026-08-26
BHVN 2026-08-27 Edmund Ingham